Formation of Protein Nano-Matrix Particles with Controlled Surface Architecture for Respiratory Drug Delivery
- 7 December 2010
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 28 (4) , 788-796
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Micro-particle corrugation, adhesion and inhalation aerosol efficiencyEuropean Journal of Pharmaceutical Sciences, 2008
- The Influence of Drug Morphology on Aerosolisation Efficiency of Dry Powder Inhaler FormulationsJournal of Pharmaceutical Sciences, 2008
- The nanoscale in pulmonary delivery. Part 2: formulation platformsExpert Opinion on Drug Delivery, 2007
- Physical Characterization of Component Particles Included in Dry Powder Inhalers. I. Strategy Review and Static CharacteristicsJournal of Pharmaceutical Sciences, 2007
- Inhaling medicines: delivering drugs to the body through the lungsNature Reviews Drug Discovery, 2007
- Dry powder aerosol drug delivery—Opportunities for colloid and surface scientistsColloids and Surfaces A: Physicochemical and Engineering Aspects, 2006
- How Much Particle Surface Corrugation Is Sufficient to Improve Aerosol Performance of Powders?Pharmaceutical Research, 2005
- Inhalation drug delivery devices and emerging technologiesExpert Opinion on Therapeutic Patents, 2003
- Use of Solid Corrugated Particles to Enhance Powder Aerosol PerformancePharmaceutical Research, 2001
- Spray Dried Powders and Powder Blends of Recombinant Human Deoxyribonuclease (rhDNase) for Aerosol DeliveryPharmaceutical Research, 1997